MCM
BMY icon

Moore Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Moore Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-350,000
Closed -$18.2M – 476
2014
Q1 		$18.2M Buy
+350,000
New +$18.6M 0.37% 64

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Moore Capital Management's BMY Position: Q4 2024 in Review

Moore Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2024, closing a stake of 41,925 shares — an estimated $2.17M sold.

Moore Capital Management first reported a position in BMY in Q1 2015 and held it in 12 quarters. The position peaked at $17.9M in Q4 2015. 2,486 funds tracked by Wall St. Rank hold BMY as of Q4 2024.

  • Moore Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2024 after selling out during the quarter.
  • Moore Capital Management sold 41,925 Bristol-Myers Squibb shares in Q4 2024, an estimated $2.17M.
  • Moore Capital Management first reported a position in Bristol-Myers Squibb in Q1 2015 and held it in 12 quarters.
  • Moore Capital Management's Bristol-Myers Squibb position peaked at $17.9M in Q4 2015.
  • 2,486 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.

Based on Moore Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.